Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Short Regimen for Patients With Rifampicin-resistant Isoniazid-susceptible Tuberculosis

NCT06526039 is registered in ClinicalTrials.gov with Taipei Medical University WanFang Hospital as lead sponsor.

NCT NCT06526039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06526039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Short Regimen for Patients With Rifampicin-resistant Isoniazid-susceptible Tuberculosis
Lead sponsor
Taipei Medical University WanFang Hospital
Phase
Phase 3
Overall status
Not yet recruiting
Start date
July 31, 2024
Completion date
December 31, 2029
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis, pulmonary